BRIEF RESEARCH REPORT article
Front. Neurol.
Sec. Neuro-Otology
Volume 16 - 2025 | doi: 10.3389/fneur.2025.1650470
This article is part of the Research TopicTemporal Bone Histopathology: Clinically Impactful Discoveries in NeurotologyView all 5 articles
Investigating Cochlear Cellular Dynamics in Neurofibromatosis Type 2-Associated Schwannomatosis: A Histopathological Study
Provisionally accepted
Reef K Al-Asad1,2
Drew J Montigny1,2
Jennifer T O'malley2
D. Bradley Welling2
David H Jung2,3
Andreas H Eckhard2
Judith S Kempfle1,2,3,4*- 1University of Massachusetts Chan Medical School, Worcester, United States
- 2Department of Otolaryngology and The Eaton-Peabody Laboratories, Massachusetts Eye and Ear Infirmary, Boston, United States
- 3Department of Otology and Laryngology, Harvard Medical School, Boston, United States
- 4Department of Otolaryngology, UMass Memorial Medical Center, Worcester, United States
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Sensorineural hearing loss (SNHL) is a hallmark symptom in patients with neurofibromatosis type 2associated schwannomatosis (NF2-SWN), a genetic condition caused by mutations in the Neurofibromin II gene that encodes the tumor suppressor protein Moesin-Ezrin-Radixin-Like Protein (Merlin; also known as Schwannomin). These mutations lead to the development of various tumors, including schwannomas, ependymomas and meningiomas along the vestibular nerve and the cerebellopontine angle. Original theories attributed SNHL in NF2-SWN to the mechanical compression of the vestibulocochlear nerve from the tumor itself, in addition to secretion of toxic tumor byproducts. However, the observation that SNHL can progress independently of tumor size and growth dynamics challenges this view and reveals a critical gap in our understanding of its underlying etiology. To better define cochlear changes associated with hearing loss in NF2-SWN, immunohistochemical cell type markers were used on archival postmortem temporal bone samples from both NF2-SWN patients and healthy controls and quantified the number and cellular density of neural (TUJ1), glial (SOX10), and immune cells (IBA1) within apical, middle, and basal turns of the cochlea. Our findings demonstrated a significant loss of spiral ganglion neurons, a slight increase of Schwann cells, and marked activation of cochlear macrophages in NF2-SWN cases. These findings indicate the contribution of cochlear macrophage-mediated inflammation and Schwann cell dysregulation in the pathophysiology of SNHL in NF2-SWN.
Keywords: Neurofibromatosis type 2, Schwann Cells, Macrophages, sensorineural hearing loss, NF2-SWN, spiral ganglion neurons
Received: 19 Jun 2025; Accepted: 05 Aug 2025.
Copyright: © 2025 Al-Asad, Montigny, O'malley, Welling, Jung, Eckhard and Kempfle. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Judith S Kempfle, Department of Otolaryngology and The Eaton-Peabody Laboratories, Massachusetts Eye and Ear Infirmary, Boston, United States
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.